Abstract
Objective
Fatigue is one of the most frequent and important nonmotor symptoms of patients with Parkinson disease (PD), affecting quality of life. Although, in some cases, it may be a severe and debilitating complaint, it remains relatively unexplored. The PFS-16 is a fatigue measure, specifically designed for PD patients. The aim of this study was to investigate the psychometric properties of Parkinson fatigue scale (PFS-16) in Greek PD patients.
Methods
In total, 99 patients with PD were assessed. The following psychometric properties were tested: data quality, floor/ceiling effects, reliability (internal consistency, test–retest reliability), and construct validity. Construct validity was evaluated by examining correlations with other variables including other fatigue measures such as Fatigue Severity Scale (FSS) and the vitality scale (SF-VT) of SF-36. Moreover, assumptions were explored about “known” groups concerning fatigue.
Results
The mean score for the PFS-16 was 2.95 (± 0.91); acceptability was good with negligible floor and ceiling effects. Results showed high internal consistency (Cronbach’s alpha, 0.96) and test–retest reliability (ICC, 0.93). Strong correlations were observed between the PFS-16 and other fatigue (FFS and SF-VT) measures (rs = 0.77 and − 0.70, p < 0.001), revealing appropriate validity. Furthermore, predictions for “known” groups validity were verified.
Conclusion
The Greek version of the PFS-16 showed satisfactory reliability and validity and thus can be regarded as a useful tool in assessing fatigue in PD.
Similar content being viewed by others
References
Pfeiffer RF (2016) Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 22(Suppl 1):S119–S122
Metta V, et al. (2011) The possible clinical predictors of fatigue in Parkinson’s disease: a study of 135 patients as part of international nonmotor scale validation project. Parkinsons Dis, 2011. p. 125271
Goldman JG, Stebbins GT, Leung V, Tilley BC, Goetz CG (2014) Relationships among cognitive impairment, sleep, and fatigue in Parkinson’s disease using the MDS-UPDRS. Parkinsonism Relat Disord 20(11):1135–1139
Kluger BM, Herlofson K, Chou KL, Lou JS, Goetz CG, Lang AE, Weintraub D, Friedman J (2016) Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord 31(5):625–631
Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou JS, Marsh L, Nail L, Shulman L, Taylor CB, Working Group on Fatigue in Parkinson's Disease (2007) Fatigue in Parkinson’s disease: a review. Mov Disord 22(3):297–308
Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD, on behalf of the PRIAMO study group (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649
Karlsen K, Larsen JP, Tandberg E, Jørgensen K (1999) Fatigue in patients with Parkinson’s disease. Mov Disord 14(2):237–241
Stocchi F, Abbruzzese G, Ceravolo R, Cortelli P, D'Amelio M, de Pandis MF, Fabbrini G, Pacchetti C, Pezzoli G, Tessitore A, Canesi M, Iannacone C, Zappia M, For the FORTE Study Group (2014) Prevalence of fatigue in Parkinson disease and its clinical correlates. Neurology 83(3):215–220
Alves G, Wentzel-Larsen T, Larsen JP (2004) Is fatigue an independent and persistent symptom in patients with Parkinson disease? Neurology 63(10):1908–1911
Friedman JH, Abrantes A, Sweet LH (2011) Fatigue in Parkinson’s disease. Expert Opin Pharmacother 12(13):1999–2007
Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders. Lancet 363(9413):978–988
Friedman JH et al (2016) Fatigue in Parkinson’s disease: report from a mutidisciplinary symposium. NPJ Parkinsons Dis 2
Brown RG, Dittner A, Findley L, Wessely SC (2005) The Parkinson fatigue scale. Parkinsonism Relat Disord 11(1):49–55
Friedman JH, Alves G, Hagell P, Marinus J, Marsh L, Martinez-Martin P, Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins G, Schrag A (2010) Fatigue rating scales critique and recommendations by the movement disorders society task force on rating scales for Parkinson’s disease. Mov Disord 25(7):805–822
Kummer A, Scalzo P, Cardoso F, Teixeira AL (2011) Evaluation of fatigue in Parkinson’s disease using the Brazilian version of Parkinson’s Fatigue Scale. Acta Neurol Scand 123(2):130–136
Hagell P, Rosblom T, Palhagen S (2012) A Swedish version of the 16-item Parkinson fatigue scale (PFS-16). Acta Neurol Scand 125(4):288–292
Fu R, Cui SS, du JJ, Huang P, He YC, Gao C, Luo XG, Chen SD (2017) Validation of the Parkinson Fatigue Scale in Chinese Parkinson’s disease patients. Brain Behav 7(6):e00712
Ozturk EA, Kocer BG, Umay E, Cakci A (2018) Cross-cultural adaptation and psychometric evaluations of the Turkish version of Parkinson Fatigue Scale. Qual Life Res 27:2719–2730
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653
Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P (2005) Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 8(2):94–104
Nilsson MH, Bladh S, Hagell P (2013) Fatigue in Parkinson’s disease: measurement properties of a generic and a condition-specific rating scale. J Pain Symptom Manag 46(5):737–746
Krupp LB, LaRocca N, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121–1123
Katsarou Z et al (2007) Immune factors or depression? Fatigue correlates in Parkinson’s disease. Rev Neurol 45(12):725–728
Hadjimichael O, Vollmer T, Oleen-Burkey M (2008) Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey. Health Qual Life Outcomes 6:100
Bakalidou D, Skordilis EK, Giannopoulos S, Stamboulis E, Voumvourakis K (2013) Validity and reliability of the FSS in Greek MS patients. Springerplus 2(1):304
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17(5):427–442
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22(1):41–47
Cohen, J., Statistical power analysis for the behavioral sciences. 2nd ed. ed. 1988, Hillsdale, N.J.: L. Erlbaum Associates
McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4(4):293–307
Nunnally, J.C. and I.H. Bernstein, Psychometric theory. 3rd ed. ed. 1994, New York ; London: McGraw-Hill
Streiner, D.L. and G.R. Norman, Health measurement scales: a practical guide to their development and use. 4th ed. ed. 2008, Oxford: Oxford University Press
Bowling A (2009) Research methods in health: investigating health and health services. 3rd ed. ed. Maidenhead: Open University Press
Solla P, Cannas A, Mulas CS, Perra S, Corona A, Bassareo PP, Marrosu F (2014) Association between fatigue and other motor and non-motor symptoms in Parkinson’s disease patients. J Neurol 261(2):382–391
Fu R, Luo XG, Ren Y, He ZY, Lv H (2016) Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment. Transl Neurodegener 5:9
Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G (2013) Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 80(9):800–809
Franke C, Storch A (2017) Nonmotor fluctuations in Parkinson’s disease. Int Rev Neurobiol 134:947–971
Grace J, Mendelsohn A, Friedman JH (2007) A comparison of fatigue measures in Parkinson’s disease. Parkinsonism Relat Disord 13(7):443–445
Okuma Y, Kamei S, Morita A, Yoshii F, Yamamoto T, Hashimoto S, Utsumi H, Hatano T, Hattori N, Matsumura M, Takahashi K, Nogawa S, Watanabe Y, Miyamoto T, Miyamoto M, Hirata K (2009) Fatigue in Japanese patients with Parkinson’s disease: a study using Parkinson fatigue scale. Mov Disord 24(13):1977–1983
Skorvanek M, Gdovinova Z, Rosenberger J, Ghorbani Saeedian R, Nagyova I, Groothoff JW, van Dijk JP (2015) The associations between fatigue, apathy, and depression in Parkinson’s disease. Acta Neurol Scand 131(2):80–87
Acknowledgements
We gratefully thank Prof. Brown for his permission to translate and use the PFS-16 in this study and for his useful remarks.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was carried out in accordance with the Declaration of Helsinki on Ethical Principles for Medical Research.
Conflicting interests
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dagklis, I.E., Tsantaki, E., Kazis, D. et al. The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson’s disease patients. Neurol Sci 40, 683–690 (2019). https://doi.org/10.1007/s10072-018-3695-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3695-5